Clinical Trials
Braintumor Website

There are 9 trials:
Facility: Thomas Jefferson University
NCT Trial Name# of Centers

NCT02667587

  An Investigational Immuno-therapy Study of Temozolomide Plus Radiation Therapy With Nivolumab or Placebo, for Newly Diagnosed Patients With Glioblastoma (GBM, a Malignant Brain Cancer)
121

NCT02392078

  Laser Ablation of Abnormal Neurological Tissue Using Robotic NeuroBlate System
16

NCT03150862

  A Study Assessing BGB-290 With Radiation and/or Temozolomide (TMZ) in Subjects With Newly Diagnosed or Recurrent Glioblastoma
12

NCT02743078

  Optune┬« Plus Bevacizumab in Bevacizumab-Refractory Recurrent Glioblastoma
8

NCT02389855

  Laser Ablation in Stereotactic Neurosurgery (LAISE): NeuroBlate┬« Retrospective Registry
8

NCT01651078

  Laser Ablation After Stereotactic Radiosurgery
7

NCT01703507

  Ipilimumab and Whole-Brain Radiation Therapy or Stereotactic Radiosurgery in Treating Patients With Melanoma With Brain Metastases
2

NCT02186509

  Alisertib and Fractionated Stereotactic Radiosurgery in Treating Patients With Recurrent High Grade Gliomas
1

NCT01324635

  Panobinostat and Stereotactic Radiation Therapy in Treating Patients With Brain Tumors
1



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2018 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740


Website Design By
World Wide Websites